688739 成大生物
按盤價 
27.410 +0.270 (+0.995%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 3.444 | 4.841 | 7.515 | 13.251 | 24.350 |
| 總資產報酬率 ROA (%) | 3.278 | 4.628 | 7.195 | 12.508 | 22.357 |
| 投入資產回報率 ROIC (%) | 3.435 | 4.826 | 7.490 | 13.198 | 22.112 | 邊際利潤分析 |
| 銷售毛利率 (%) | 82.916 | 83.650 | 87.114 | 89.851 | 86.253 |
| 營業利潤率 (%) | 31.242 | 33.015 | 46.246 | 48.979 | 54.274 |
| 息稅前利潤/營業總收入 (%) | 28.017 | 28.800 | 42.972 | 49.201 | 53.120 |
| 淨利潤/營業總收入 (%) | 25.309 | 26.623 | 39.340 | 42.743 | 46.011 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 106.272 | 112.110 | 97.586 | 98.596 | 91.800 |
| 價值變動淨收益/利潤總額(%) | -0.327 | 5.747 | 3.252 | 1.378 | 8.393 |
| 營業外收支淨額/利潤總額(%) | -0.451 | -0.246 | -0.154 | 0.803 | -1.897 | 償債能力分析 |
| 流動比率 (X) | 18.622 | 20.317 | 28.228 | 26.980 | 13.324 |
| 速動比率 (X) | 17.441 | 19.133 | 26.471 | 25.647 | 12.092 |
| 資產負債率 (%) | 4.824 | 4.783 | 4.039 | 4.500 | 8.043 |
| 帶息債務/全部投入資本 (%) | -0.902 | -0.976 | -1.100 | -1.205 | -- |
| 股東權益/帶息債務 (%) | -11,065.118 | -10,216.152 | -9,068.384 | -8,265.151 | -3,562.374 |
| 股東權益/負債合計 (%) | 1,973.059 | 1,990.571 | 2,375.782 | 2,122.005 | 1,143.383 |
| 利息保障倍數 (X) | -9.080 | -6.967 | -13.415 | -282.688 | -368.722 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 235.874 | 225.605 | 205.242 | 126.644 | 0.000 |
| 存貨周轉天數 (天) | 527.914 | 567.585 | 665.725 | 566.538 | 0.000 |
| 備註： | 即時報價更新時間為 19/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
